Lewes, DE -- (SBWire) -- 12/11/2018 --Global Artificial Pancreas Devices Systems market will register a 13.8% CAGR in terms of revenue, reach US$ 120 million by 2023, from US$ 56 million in 2017
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Over the next five years, study projects that Artificial Pancreas Devices Systems will register a 13.8% CAGR in terms of revenue, reach US$ 120 million by 2023, from US$ 56 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Devices Systems market by product type, application, key manufacturers and key regions.
To calculate the market size, study considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segmentation by application:
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artificial Pancreas Devices Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Artificial Pancreas Devices Systems market by identifying its various subsegments.
Focuses on the key global Artificial Pancreas Devices Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artificial Pancreas Devices Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artificial Pancreas Devices Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Spanning over 138 pages "Forecast of Global Artificial Pancreas Devices Systems Consumption Market 2023" report covers Scope of the Report, Executive Summary, Global Artificial Pancreas Devices Systems by Players, Artificial Pancreas Devices Systems by Regions, Market Drivers, Challenges and Trends, Marketing, Distributors and Customer, Global Artificial Pancreas Devices Systems Market Forecast, Key Players Analysis, Research Findings and Conclusion.
Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-artificial-pancreas-devices-systems-consumption-market-2023
Find all Healthcare Reports at: https://www.marketresearchreports.com/healthcare
For related reports please visit: https://www.marketresearchreports.com/search/site/Artificial%2520Pancreas%2520Devices%2520System
Read our Interactive Market Research Blog
About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: https://www.marketresearchreports.com/contact
